Gene: BLVRA
Official Full Name: biliverdin reductase Aprovided by HGNC
Gene Summary: The protein encoded by this gene belongs to the biliverdin reductase family, members of which catalyze the conversion of biliverdin to bilirubin in the presence of NADPH or NADH. Mutations in this gene are associated with hyperbiliverdinemia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04643 | BLVRA Knockout cell line (HeLa) | Human | BLVRA | 1:3~1:6 | Negative | Online Inquiry |
KO04644 | BLVRA Knockout cell line (HCT 116) | Human | BLVRA | 1:2~1:4 | Negative | Online Inquiry |
KO04645 | BLVRA Knockout cell line (HEK293) | Human | BLVRA | 1:3~1:6 | Negative | Online Inquiry |
KO04646 | BLVRA Knockout cell line (A549) | Human | BLVRA | 1:3~1:4 | Negative | Online Inquiry |
BLVRA Gene Knockout Cell Lines are genetically modified cellular systems designed to disrupt the expression of the Biliverdin Reductase A (BLVRA) gene, which plays a crucial role in heme metabolism and antioxidant defense mechanisms. By utilizing advanced CRISPR-Cas9 gene editing techniques, these cell lines ensure precise and efficient knockout of the BLVRA gene, thereby allowing researchers to investigate the biological implications of BLVRA deficiency.
The key function of BLVRA knockout cell lines lies in their ability to facilitate in-depth studies of the heme catabolism pathway and its impact on cellular processes. Without functional BLVRA, cells exhibit altered levels of bilirubin and reactive oxygen species, which can lead to significant changes in redox state and metabolic activity. This makes them an indispensable tool for researchers examining oxidative stress responses, neurodegenerative diseases, and conditions related to dysregulated heme metabolism.
The scientific importance of BLVRA knockout cell lines cannot be overstated, as they serve as a valuable resource in both basic and translational research settings. In academic investigations, these cell lines offer insights into the molecular functions of BLVRA, while in clinical settings, they hold promise for developing novel therapeutic strategies for diseases associated with oxidative stress.
Compared to current alternatives, our BLVRA knockout cell lines offer enhanced specificity and reproducibility due to rigorously validated knockout efficiency and characterizations. Additionally, the availability of these cell lines in multiple tissue backgrounds allows for versatile applications across various experimental models.
For researchers and clinicians alike, the BLVRA Gene Knockout Cell Lines represent a powerful tool that bridges the gap between basic science and clinical application, ultimately elucidating the role of heme metabolism in human health and disease. Our company is committed to providing high-quality biological products that empower scientific discoveries and advancements, backed by a team of experts dedicated to supporting your research needs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.